NCT06892158 Massage Impact on Sleep in Pediatric Oncology
| NCT ID | NCT06892158 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Hospital of Philadelphia |
| Condition | Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2025-01-23 |
| Primary Completion | 2028-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2025-01-23 with a primary completion date of 2028-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to determine the impact of massage therapy for pediatric patients receiving intensive chemotherapy or stem cell transplant (SCT).
Eligibility Criteria
Inclusion Criteria: 1. Diagnosis of cancer, such as acute myeloid leukemia (AML) or relapsed acute lymphoblastic leukemia (rALL) OR admitted to receive autologous or allogeneic HSCT for any indication 2. Expected to be an inpatient for at least 21 days 3. Aged 12 to 21 years at enrollment. 4. Inpatient at Children's National or Children's Hospital of Philadelphia (CHOP). Exclusion Criteria: 1. Cognitive impairment sufficient to preclude completing questionnaires appropriately 2. Insufficient knowledge of English or Spanish that would prohibit completing the study instruments 3. Previous enrollment
Contact & Investigator
Tracey Jubelirer, MD
PRINCIPAL INVESTIGATOR
Children's Hospital of Philadelphia
Frequently Asked Questions
Who can join the NCT06892158 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 21 Years, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06892158 currently recruiting?
Yes, NCT06892158 is actively recruiting participants. Contact the research team at vernaul@chop.edu for enrollment information.
Where is the NCT06892158 trial being conducted?
This trial is being conducted at Washington D.C., United States, Philadelphia, United States.
Who is sponsoring the NCT06892158 clinical trial?
NCT06892158 is sponsored by Children's Hospital of Philadelphia. The principal investigator is Tracey Jubelirer, MD at Children's Hospital of Philadelphia. The trial plans to enroll 70 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.